|Place of Origin:||China|
|Certification:||COA, HPLC MR|
|Model Number:||HBY-Triptorelin Acetate|
|Minimum Order Quantity:||1BOX|
|Packaging Details:||2mg/vial, 10vials/box|
|Delivery Time:||3-5 work days after your payment|
|Payment Terms:||MoneyGram, Western Union, T/T|
|Name:||Breast Cancer Treatment White PowderTriptorelin Acetate CAS 140194-24-7||Appearance:||Sterile Filtered White Lyophilized (freeze-dried) Powder.|
|Storage:||Store At -20°C||MOQ:||1BOX|
What is Breast Cancer Treatment White PowderTriptorelin Acetate?
Basic Information Form:
|Product Name||Breast Cancer Treatment White PowderTriptorelin Acetate|
|Appearance||White freeze dried powder|
|Place of origin||China|
|Storage||Store at -20°C|
Triptorelin C64H82N18O13, Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 is a synthetic analogue of gonadorelin (GNRH).
As a result of the substitution of the 6th amino acid residue in the native molecule, the agonistic effect is more pronounced and the plasma half-life prolonged.
Triptorelin Acetate is used as a GNRH agonist. It decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by causing constant stimulation of the pituitary. Triptorelin may be used in the treatment of hormone-responsive cancers such as breast cancer or prostate cancer, precocious puberty, estrogen-dependent conditions, and assisted reproduction.
Triptorelin is a GNRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo.
1. Triptorelin can improve the pregnancy rate by 12% to 15% in ewes6 and downregulate ovarian GNRHR-I expression of female rats, especially in late-growing follicles.
2. Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins.
3. Triptorelin may be used in the treatment of hormone-responsive cancers such as breast cancer or prostate cancer, precocious puberty, estrogen-dependent conditions, and assisted reproduction.